myelodysplastic syndromes (MDS) | Page 5 | Aplastic Anemia and MDS International Foundation

myelodysplastic syndromes (MDS)

A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes

Author(s): 
Platzbecker U, Symeonidis A, Oliva EN, Goede JS, Delforge M, Mayer J, Slama B, Badre S, Gasal E, Mehta B, Franklin J
Primary Author: 
Platzbecker U
Journal Title: 
Leukemia
Original Publication Date: 
Jun 2017

Use of

Bone Marrow Diseases: 

Outcome of patients treated for myelodysplastic syndromes with 5q deletion after failure of lenalidomide therapy.

Author(s): 
Prebet T, Cluzeau T, Park S, Sekeres MA, Germing U, Ades L, Platzbecker U, Gotze K, Vey N, Oliva E, Sugrue MM, Bally C, Kelaidi C, Ali NA, Fenaux P, Gore SD, Komrokji R
Primary Author: 
Prebet T
Journal Title: 
Oncotarget
Original Publication Date: 
Jun 2017

While

Bone Marrow Diseases: 

Minneapolis

Thank you for attending the 2017 Minneapolis Patient and Family Conference.

Event Date: 
Sat, 07/22/2017 -
8:00am to 3:30pm
Conference Event Type: 

Vincent Rusak

His father’s quadruple bypass surgery, as well as a deep compassion for his fellow man, were Vince's motivation for contributing to his local blood banks every six to nine months. Little did he know that this selfless habit would someday save his life.

Hematopoietic Cell Transplantation in Myelodysplastic Syndromes after Treatment with Hypomethylating Agents

Author(s): 
Festuccia M, Baker K, Gooley TA, Sandmaier BM, Deeg HJ, Scott BL
Primary Author: 
Festuccia M
Journal Title: 
Biol Blood Marrow Transplant
Original Publication Date: 
Jun 2017

The prognosis of patients with

Bone Marrow Diseases: 

Mutated ASXL1 and number of somatic mutations as possible indicators of progression to chronic myelomonocytic leukemia of myelodysplastic syndromes with single or multilineage dysplasia

Author(s): 
Valencia-Martinez A, Sanna A, Masala E, Contini E, Brogi A, Gozzini A, Santini V
Primary Author: 
Valencia-Martinez A
Journal Title: 
Haematologica
Original Publication Date: 
May 2017

No abstract available.

Bone Marrow Diseases: 

Nashville

Thank you for attending the 2017 Nashville Patient and Family Conference.

Event Date: 
Sat, 06/24/2017 -
7:30am to 1:30pm
Conference Event Type: 

Patterns of treatment and costs associated with transfusion burden in patients with myelodysplastic syndromes.

Author(s): 
DeZern AE, Binder G, Rizvi S, Corvino FA, Arikian SR, Surinach A, Lee J, Smith BD
Primary Author: 
DeZern AE
Journal Title: 
Leuk Lymphoma
Original Publication Date: 
May 2017

Transfusion dependence (TD) among

Bone Marrow Diseases: 

Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117

Author(s): 
Sekeres MA, Othus M, List AF, Odenike O, Stone RM, Gore SD, Litzow MR, Buckstein R, Fang M, Roulston D, Bloomfield CD, Moseley A, Nazha A, Zhang Y, Velasco MR, Gaur R, Atallah E, Attar EC, Cook EK, Cull AH, Rauh MJ, Appelbaum FR, Erba HP
Primary Author: 
Sekeres MA
Journal Title: 
J Clin Oncol
Original Publication Date: 
May 2017

Purpose

Bone Marrow Diseases: